Analysis-SpaceX Debut Draws a Crowd, but Few Recent Hot IPOs Outpace the Market

Reuters found that investors in the 50 highest-valued IPOs over the past five years would have outperformed by buying an S&P 500 index fund about three-quarters of the time, with average IPO gains of 27% versus 53% for the S&P 500. The piece warns that extremely rich valuations, including SpaceX's expected $1.75 trillion target and nearly 100 price-to-sales ratio, do not guarantee attractive returns. Biggest winners cited were Astera Labs (+700%) and Arm (+400%), while Didi (-74%), Rivian (-82%) and Figma (-35%) highlight the downside risk.

Analysis

The signal here is less about any one listing and more about valuation discipline breaking down at the top end of private markets. When a marquee IPO prices at a multiple that implies perfection, the public market usually forces a mean reversion through either slower growth, margin pressure, or simply a reset in what investors are willing to pay once lockup supply and real quarterly disclosures begin. That dynamic is especially important for capital-light narrative businesses, where scarcity value can support the debut but not necessarily the first 12-18 months of public ownership.

The second-order winner is the infrastructure layer around private-market access, not the issuers themselves. Platforms that can intermediate pre-IPO demand or offer fractional exposure benefit from retail FOMO and from the fact that many buyers want exposure to the story, not necessarily to underwriting risk. By contrast, late-stage VC backers may use a high-profile IPO window to mark portfolios and distribute supply into strength, which can cap upside quickly once the initial allocation scarcity fades.

The current setup also argues that the market is conflating AI adjacency with durable monetization. Hardware-enablers with real design-win visibility and shorter product cycles deserve a different multiple regime than story-driven software or loss-making consumer hardware, and that distinction is likely to widen over the next few quarters. The weakest links are businesses with high cash burn and no near-term path to operating leverage, where any disappointment in growth rates can create a sharp de-rating because the starting valuation leaves no cushion.

Consensus appears to be underestimating how often first-day price discovery overshoots fundamentals in the wrong direction. The opportunity is not to short every hyped IPO outright, but to fade the weakest risk/reward profiles after the first post-lockup rally or to pair quality AI infrastructure against speculative names. If market conditions stay risk-on, the best longs may still work—but the hurdle rate is now extremely high, and the downside asymmetry is worse than investors are pricing.

Key Decisions for Investors

• Avoid chasing the debut in the largest headline IPOs; wait 60-120 days post-listing for lockup expiry and first earnings before initiating any long exposure. Risk/reward is poor when the implied multiple assumes flawless execution.
• Relative-value pair: long ALAB / short a basket of high-burn, narrative-driven growth names once listed. ALAB has clearer demand visibility and more defensible product economics; target 3-6 month horizon.
• Maintain or add to shorts in RIVN on strength. The cash burn profile means any multiple expansion is fragile; use rallies to build via puts or put spreads with 2-4 month tenor.
• Fade FIG on any post-IPO volatility squeeze by buying downside put spreads if generative AI commoditization fears persist. Best entry is after a failed breakout, not immediately on weakness.
• For SOFI and BABA, treat the article as a sentiment-negative backdrop rather than a direct fundamental call; only use them as financing legs in pair trades, not standalone directional shorts.